Ani (Ani 01)
Felbamate Tablet
Product Images NDC 62559-730
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 62559-730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ani (Ani 02)
Ani (Ani)
Structural Formula (Felbamate Tablets 1)
Image 01
NDC 62559-730-01 is a medication called Felbamate, which comes in the form of tablets. Each tablet contains 400 mg of Felbamate USP. The usual dosage should be determined by the prescribing information included. The medication guide should be dispensed with each prescription. It's important to keep the medication in a tight container and out of the reach of children. The medication is a product of India and distributed by ANI Pharmaceuticals, Inc.*
Image 02
NDC 62559-731-01 is a medication containing Felbamate USP that comes in a pack of 100 tablets. It is only available through prescription and each tablet contains 600 mg of Felbamate USP. There is an accompanying medication guide that should be given to each patient. It is recommended to store the medication in a tight container at 20°C to 25°C (68°F to 77°F). The medication is a product of India but manufactured in Taiwan by Bora Pharmaceutical Laboratories Inc., and distributed by ANI Pharmaceuticals, Inc. in Baudette, MN 56623.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
